Arbutus Biopharma
ABUS
Arbutus Biopharma (ABUS) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Chardan Capital | Maintained | Buy | $5.00 | Nov 14, 2025 |
| Chardan Capital | Maintained | Buy | $5.00 | Aug 11, 2025 |
| Chardan Capital | Maintained | Buy | $5.00 | Mar 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Jan 21, 2025 |
| Chardan Capital | Maintained | Buy | $5.00 from $4.50 | Nov 20, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Nov 18, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Nov 7, 2024 |
| Chardan Capital | Maintained | Buy | $4.50 from $4.00 | Nov 6, 2024 |
| Jefferies | Maintained | Buy | $7.00 from $5.00 | Sep 5, 2024 |
| JMP Securities | Maintained | Market Outperform | $5.00 from $4.00 | Aug 2, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Jun 7, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Jun 6, 2024 |
| Chardan Capital | Maintained | Buy | $4.00 | Jun 5, 2024 |
| Chardan Capital | Maintained | Buy | $4.00 | May 3, 2024 |
| JMP Securities | Maintained | Market Outperform | $4.00 | Apr 4, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $6.00 | Mar 1, 2024 |
| Chardan Capital | Maintained | Buy | $4.00 | Mar 1, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Sep 12, 2023 |
| Chardan Capital | Maintained | Buy | $6.00 | Aug 4, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Aug 4, 2023 |
Frequently asked questions
What is the latest analyst rating on ABUS?
On Nov 14, 2025, Chardan Capital maintained Arbutus Biopharma at Buy with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.